What is a chronic leukemia?
In chronic leukemia, the cells can mature partly (and more are like normal white blood cells). but not completely. These cells may look fairly normal, but they're not. They generally don't fight infection as well as normal white blood cells do. The leukemia cells survive longer than normal cells, and build up, crowding out normal cells in the bone marrow. It can take a long time before chronic leukemias cause problems, and most people can live with them for many years. But chronic leukemias tend to be harder to cure than acute leukemias.
What is a lymphocytic leukemia?
Leukemia is myeloid or lymphocytic depending on which bone marrow cells 4 the cancer starts in.
Lymphocytic leukemias (also known as lymphoid or lymphoblastic leukemia) start in the cells that become lymphocytes. Lymphomas are also cancers that start in those cells. The main difference between lymphocytic leukemias and lymphomas is that in leukemia, the cancer cells are mainly in the bone marrow and blood, while in lymphoma they tend to be in lymph nodes and other tissues.
Different types of CLL
Doctors agree that there seem to be 2 different kinds of CLL:
One kind of CLL grows very slowly. So it may take a long time before the patient needs treatment. The other kind of CLL grows faster and is a more serious disease. The leukemia cells from these 2 types look alike, but lab tests can tell the difference between them. The tests look for proteins called ZAP-70 and CD38. If the CLL cells have low amounts of these proteins, the leukemia tends to grow more slowly and have better long-term outcomes.
Rare forms of lymphocytic leukemia
The common form of CLL starts in B lymphocytes. But there are some rare types of leukemia that share some features with CLL.
Prolymphocytic leukemia (PLL):
In this type of leukemia the cancer cells are a lot like normal cells called prolymphocytes. These are immature forms of B lymphocytes (B-PLL) or T lymphocytes (T-PLL). Both B-PLL and T-PLL tend to grow and spread faster than the usual type of CLL. Most people with it will respond to some form of treatment, but over time they tend to relapse (the cancer comes back). PLL may develop in someone who already has CLL (in which case it tends to be more aggressive), but it can also occur in people who have never had CLL.
Large granular lymphocyte (LGL) leukemia: This is another rare form of chronic leukemia. The cancer cells are large and have features of either T lymphocytes or another type of lymphocyte called natural killer (NK) cells. Most LGL leukemias are slow-growing, but a small number are more aggressive (they grow and spread quickly). Drugs that suppress the immune system may help, but the aggressive types are very hard to treat.
Hairy cell leukemia (HCL):
This is rare cancer of the lymphocytes that tends to progress slowly. The cancer cells are a type of B lymphocyte but they're different from those seen in CLL. There are also important differences in symptoms and treatment. This type of leukemia gets its name from the way the cells look under the microscope --they have fine projections on their surface that make them look "hairy." Treatment for HCL 5 
Bone marrow
Blood cells are made in the bone marrow.
Bone marrow is the soft inner part of some bones, like the skull, shoulder blades, ribs, pelvis, and backbones. Bone marrow is made up of:
A small number of blood stem cells 
Types of blood cells
Red blood cells carry oxygen from the lungs to all other tissues in the body, and take carbon dioxide back to the lungs to be removed. Having too few red blood cells (anemia) can make you feel tired, weak, and short of breath because your body tissues aren't getting enough oxygen.
Platelets are actually cell pieces made by a type of bone marrow cell called the megakaryocyte. Platelets are important in plugging up holes in blood vessels caused by cuts or bruises. Having too few platelets (thrombocytopenia) may cause you to bleed or bruise easily.
White blood cells help the body fight infections. Having too few white blood cells (neutropenia) lowers your immune system and can make you more likely to get an infection.

Types of white blood cells
Lymphocytes are mature, infection-fighting cells that develop from lymphoblasts, a type of blood stem cell in the bone marrow. Lymphocytes are the main cells that make up lymphoid tissue, a major part of the immune system. Lymphoid tissue is found in lymph nodes, the thymus gland, the spleen, the tonsils, and adenoids. It's also scattered throughout the digestive and respiratory systems and the bone marrow. 
Key Statistics for Chronic Lymphocytic Leukemia
The CLL mainly affects older adults. The average age at the time of diagnosis is around 70years. It's rarely seen in people under age 40, and is extremely rare in children.
Visit the American Cancer Society's Cancer Statistics Center for more key statistics.
What's New in Chronic Lymphocytic Leukemia Research and Treatment?
Research on chronic lymphocytic leukemia (CLL) is taking place in many university hospitals, medical centers, and other institutions around the world. Each year, scientists find out more about what causes the disease, how to prevent it, and how to better treat it.
Most experts agree that treatment in a clinical trial 1 should be considered for any type or stage of CLL. This way people can get the best treatment available now and may also get the new treatments that are thought to be even better. The new and promising treatments discussed here are only available in clinical trials.
Genetics of chronic lymphocytic leukemia
Scientists are learning a lot about the biology of CLL cells, such as details about the gene changes in the cells. This information is being used to help know whether treatment needs to be started, what type of treatment to use, which treatments are likely to work, and what long-term outlook can be expected. It's also changing the way CLL is treated 2 . New treatments that focus on these gene changes are proving to have a great impact on the treatment options available and how well treatment is tolerated, as well as how well it works.
Learning about these gene changes is also helping researchers understand why these cells grow too quickly, live too long, and fail to develop into normal blood cells.
As doctors learn more about the many gene changes that can take place in CLL cells, they're looking at the need to break CLL into groups of sub-types. This could lead to better understanding of the many treatment outcomes seen in people with CLL today. It could also help researchers learn more about how CLL develops.
New drugs for chronic lymphocytic leukemia
Dozens of new drugs are being tested for use against CLL. Most of these drugs are targeted 3 at specific parts of cancer cells (like gene changes in CLL cells).
Doctors are looking at the best ways to use these drugs, as well as how they can be used in combinations or along with chemo to get even better results. They're also looking at how these drugs might be used in elderly patients who may have health problems that keep them from getting standard chemo.
Vaccine therapy
The use of vaccines 4 as cancer treatment is a research interest in many different kinds of cancer. These vaccines do not prevent cancer. Instead, they try to get the immune system to mount an attack against cancer cells in the body. Early studies are using vaccines made from the patient's CLL cells and a protein that stimulates the immune system to boost immune system's ability to kill the CLL cells. These studies are in very early phases, and it will take time before we know whether vaccine therapy works.
CAR T-cell therapy
CAR (chimeric antigen receptor) T-cell therapy 5 is another way of getting your immune system to find and kill CLL cells. The patient's T cells, a type of white blood cell, are removed, reprogrammed, and grown (multiplied) in the lab. They're then given back to the patient so they can destroy CLL cells in the patient's body. These treatments have
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